Yuyu Pharma, Inc.

Symbol: 000225.KS

KSC

4985

KRW

Markedspris i dag

  • -11.8661

    P/E-forhold

  • -0.1679

    PEG Ratio

  • 76.98B

    MRK Cap

  • 0.00%

    DIV Udbytte

Yuyu Pharma, Inc. (000225-KS) Årsregnskaber

På diagrammet kan du se standardtallene i dynamik for Yuyu Pharma, Inc. (000225.KS). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Balance

Når vi dykker ned i den skattemæssige udvikling for Yuyu Pharma, Inc., ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172015201420132012201120102009200820072006

balance-sheet.row.cash-and-short-term-investments

030604.930777.650263.5
20502.8
26846.2
27512.5
20312.4
10333.3
11668.6
11584.9
2672.9
3307.8
2075.7
1958.3
5749.4
2745.2
5326.8

balance-sheet.row.short-term-investments

01749.34939.1-2909.2
180
-2793.8
546
500
500
550
4210.5
64.4
6.5
24.5
190.1
3512
240.2
2021.8

balance-sheet.row.net-receivables

024454.525308.822905.2
19848.4
21077.5
25516
23564.6
25893.3
25681.1
25223.3
22569.7
24637.1
27256.9
28185.3
0
49181.4
33096.6

balance-sheet.row.inventory

044152.23983225225.3
23688.9
17016
15616
19593.4
12789.1
8224
7097.7
8126.5
5480.8
5356.8
5984.8
10586.2
12881
9921.1

balance-sheet.row.other-current-assets

02384.9439.3494
426.4
114.2
225.2
0
0
0
0
0
0
0
0
34154.8
0
0

balance-sheet.row.total-current-assets

0101596.596357.798887.9
64466.6
65053.9
68869.7
63470.4
49015.7
45573.7
43905.9
33369.1
33425.8
34689.5
36128.4
50490.4
64807.6
48344.5

balance-sheet.row.property-plant-equipment-net

081402.781371.380341.4
78073.3
63262.5
57811.7
49722
47225.6
46518.8
44845
45767.9
46266.9
45559.4
47267.4
41095.5
41701.6
43958.1

balance-sheet.row.goodwill

0503.250.850.8
50.8
50.8
50.8
50.8
50.8
50.8
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

03764.53666.54087.1
3785.5
1924.7
1651.9
1822
2172.4
2085.7
2209.2
2152
2444.5
900.9
1157.8
1082.4
903.7
1317.6

balance-sheet.row.goodwill-and-intangible-assets

04267.73717.34137.9
3836.3
1975.5
1702.8
1872.9
2223.3
2136.5
2209.2
2152
2444.5
900.9
1157.8
1082.4
903.7
1317.6

balance-sheet.row.long-term-investments

010815.21004.78945
4897.4
6819.7
3381.1
3201.9
3152.5
4087
-1183.2
3852.1
3153.2
5882.3
6748.8
2491.4
4917
3835.4

balance-sheet.row.tax-assets

03764.5-1004.7-8945
3128.8
108.3
2962.5
168.4
674.4
929.7
283.5
1213.2
962.7
1527.5
1413
1774.5
1051.8
364.9

balance-sheet.row.other-non-current-assets

0-3633.113758.79618.1
498.7
498.7
498.7
3055.5
2035.7
2154.9
6204.1
2325.6
2253.8
4318.2
3896.9
8727.7
13491.3
23296.1

balance-sheet.row.total-non-current-assets

09661798847.394097.4
90434.5
72664.7
66356.7
58020.8
55311.5
55826.9
52358.7
55310.8
55081.1
58188.2
60483.9
55171.4
62065.4
72772.1

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0198213.5195205.1192985.3
154901
137718.6
135226.3
121491.2
104327.2
101400.5
96264.5
88679.9
88506.9
92877.6
96612.3
105661.8
126873
121116.6

balance-sheet.row.account-payables

010951.815840.58982.3
5286.8
6385.1
5056.8
8453.3
4879.9
3224.4
4355.4
4938.2
3011.9
3397.2
1257.3
1101.6
7234.9
3197.6

balance-sheet.row.short-term-debt

025386.23742510427.3
4978.2
23872.5
12366.2
18070
17444
5029.5
3896.5
900
6050.3
9250
10000
18000
14314.6
16785.5

balance-sheet.row.tax-payables

0574.8515.41004.5
647.6
2120
1059.4
729.7
972.1
1558.7
669.7
1447.6
699.6
783.7
1128
1470.6
2325.1
4296.9

balance-sheet.row.long-term-debt-total

0136401851.428739.1
14971.8
3070.1
14844.6
1349.5
0
0
3956
200
0
0
3750
8750
17690.8
24442.3

Deferred Revenue Non Current

0380.902649.5
2685.1
0
2081.6
0
0
0
0
0
0
0
3217.9
4585.3
4298.5
3079.4

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

012247.110366.10
0
0
0
0
0
0
0
0
0
0
5337.7
0
0
0

balance-sheet.row.total-non-current-liabilities

027882.77515.534285.5
19465.9
4678.3
20566.5
3173.8
1389.8
7010.8
8426.5
6010.1
4674.1
5205.5
9558.3
13880.5
23281.7
27815.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0380.9793.8697.8
969.6
822.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

077857.97183164300.2
37864.6
47174
48354.1
38657.4
30596.6
29911.5
23988.1
19178.5
21278.1
22235.5
26153.4
41070
54398.2
57816.9

balance-sheet.row.preferred-stock

02592.52592.52592.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5
1297.5

balance-sheet.row.common-stock

017609.217609.217609.2
8412.1
6745.4
6745.4
6745.4
6538.2
6361.8
6208.3
6208.3
6208.3
6208.3
6208.3
6208.3
6208.3
6208.3

balance-sheet.row.retained-earnings

013946.531395.936540.4
41914.3
39900.5
37018.9
34766.2
27520.3
29110.1
38312.6
37150
35205.7
38650.5
38023.3
36208.2
43816.8
31832.2

balance-sheet.row.accumulated-other-comprehensive-income-loss

025885.42379624242.5
20195.5
8840.2
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

052154.141422.743296.7
42540.1
31910.9
40730.5
39154
37502.7
33650
25554.1
24765
24561.1
24485.9
24929.8
20877.7
21152.1
23961.6

balance-sheet.row.total-stockholders-equity

0112187.6116816.2124281.2
114359.5
88694.6
85792.4
81963.2
72858.8
70419.3
71372.5
69420.8
67272.6
70642.2
70458.9
64591.7
72474.8
63299.7

balance-sheet.row.total-liabilities-and-stockholders-equity

0198213.5195205.1192985.3
154901
137718.6
135226.3
121491.2
104327.2
101400.5
96264.5
88679.9
88506.9
92877.6
96612.3
105661.8
126873
121116.6

balance-sheet.row.minority-interest

081686557.84403.9
2677
1850.1
1079.9
870.5
871.8
1069.7
903.9
80.6
-43.9
0
0
0
0
0

balance-sheet.row.total-equity

0120355.7123374128685.1
117036.4
90544.7
86872.3
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

010815.25943.86035.9
5077.4
4025.9
3927
3701.9
3652.5
4637
3027.3
3916.5
3159.7
5906.8
6938.9
6003.4
5157.2
5857.2

balance-sheet.row.total-debt

039407.239276.439166.5
19949.9
26942.6
27210.8
19419.5
17444
5029.5
7852.5
1100
6050.3
9250
13750
26750
32005.4
41227.8

balance-sheet.row.net-debt

08802.313437.8-11097
-372.9
96.3
244.3
-393
7610.7
-6089.1
478.1
-1508.5
2749
7198.7
11981.9
24512.6
29500.4
37922.8

Pengestrømsopgørelse

Det økonomiske landskab for Yuyu Pharma, Inc. har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172015201420132012201120102009200820072006

cash-flows.row.net-income

0-7180.9-4425.4-920.3
2412.6
5563.3
4312.1
4288.5
-403.7
-7363.4
1931.9
2986
1908.2
1117.3
2273.4
-5687.4
13566.1
8558.4

cash-flows.row.depreciation-and-amortization

05607.35027.44503
3899.4
3120.7
2127
1460.9
1542.2
1510.4
1632.5
1549
1694.8
2245.8
2690.3
3313.8
4588.9
4898.3

cash-flows.row.deferred-income-tax

0002698.8
521.5
775.5
1434.7
256.9
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

000-42.4
85.8
114.2
178.7
195.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-6772.5-13150.7-3703.6
-11187.5
2158.8
-2818.7
-5241.5
-17138.1
2712.8
-4561.8
-1766.3
1560.5
-1231.1
5685.7
13650.8
-9771.9
-8404.6

cash-flows.row.account-receivables

0918.9-1760.7-3016.3
316.7
1981.2
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-3424.1-15133.5-1366.8
-6839.5
-1130.3
3741.4
-5660.5
-4495.9
-988.2
1154.2
-3072.8
315
628
4601.4
2294.8
-2959.9
6041.9

cash-flows.row.account-payables

0-5527.37090.73715.8
-1048.9
1340.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

01260-3347.2-3036.3
-3615.7
-32.7
-6560.2
419
-12642.2
3701
-5716
1306.5
1245.5
-1859.1
1084.4
11356
-6812
-14446.5

cash-flows.row.other-non-cash-items

09185.26319.71973.2
1599.1
1452.8
876.3
375.2
4316.1
4503.5
222.3
3741.9
1510.4
3682.7
-1242.2
1796.9
-5119.2
1748.9

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-5106.2-5567.7-6750.9
-14289.2
-8736.5
-10069.7
-4534
-2215.7
-637.8
-1373.6
-1031.9
-496.3
-392.7
-983.8
-2887.1
-2400.5
-14825.2

cash-flows.row.acquisitions-net

0-770.94.61029
622.1
1734.9
0
340.3
2.6
0.5
28.3
-51.2
-200
0
-500
-30.7
233.5
-374.4

cash-flows.row.purchases-of-investments

0-606-3833.6-822.3
-1075.8
-1001.4
-101.9
-52.4
-2989.3
-1455.2
-11677.9
-523.6
0
0
-2410
-5479.3
-8294.3
-6545.8

cash-flows.row.sales-maturities-of-investments

03047.3506701.6
149.5
1628.6
0
9.6
1479.3
3781.6
8414.7
7
24.8
192.7
6540.3
244
2562
5505.7

cash-flows.row.other-investing-activites

0-346.4346.9-47
2451.9
1042.1
232.1
1542
196.8
1180
1856.6
212.8
164.1
-619
2368
1894.4
16576.1
-6540.8

cash-flows.row.net-cash-used-for-investing-activites

0-3782.2-8543.8-5889.6
-12141.5
-5332.3
-9939.5
-2694.5
-3526.2
2869
-2751.9
-1386.9
-507.4
-818.9
5014.4
-6258.7
8676.9
-22780.5

cash-flows.row.debt-repayment

0-10449.7-6253.3-906.8
-4406.8
-9906.8
-9771.6
-2210.6
-2000
-3866
-1772.5
-5260.2
-9350
-10000
-18000
-10721.9
-16785.5
-12239

cash-flows.row.common-stock-issued

0000
0
0
23171.7
1350
2191.1
1000
7.7
180.8
0
5500
5000
5436.9
7563.1
23376.8

cash-flows.row.common-stock-repurchased

00-1785.20
-819.5
0
-976.9
-11.4
14965
3450.9
10031.4
-19
0
-370.4
-2410.6
-245.3
-2812.3
-259.3

cash-flows.row.dividends-paid

0-2001.7-2033.7-1851.2
-1519.4
-1443.9
-1384
-1274.1
-1202.2
-1070.6
-953
-718
-600.5
-490.1
-458.2
-1921.3
-1581.5
-1455.7

cash-flows.row.other-financing-activites

020160.8989.134071
15256.4
3313.5
-92.8
4421.1
-12.6
-10
978.7
0
4733.5
487.8
890
610
884.5
850.3

cash-flows.row.net-cash-used-provided-by-financing-activities

07709.4-9083.231313
8510.7
-8037.1
10946.3
2275.1
13941.3
-495.7
8292.3
-5816.4
-5216.9
-4872.7
-14978.8
-6841.5
-12731.8
10273.1

cash-flows.row.effect-of-forex-changes-on-cash

00-568.98.6
-223.5
63.8
37.2
-8.6
-16.9
7.6
0.6
0
5.5
0
0
0
0
0

cash-flows.row.net-change-in-cash

04766.3-24424.929940.6
-6523.4
-120.3
7154.1
907.4
-1285.3
3744.2
4765.9
-692.8
955.1
122.9
-557.2
-26.1
-791.1
-5706.4

cash-flows.row.cash-at-end-of-period

030604.925838.650263.5
20322.8
26846.2
26966.5
19812.4
9833.3
11118.6
7374.4
2608.5
3301.3
2053.6
1930.7
2487.8
2513.9
3304.9

cash-flows.row.cash-at-beginning-of-period

025838.650263.520322.8
26846.2
26966.5
19812.4
18905.1
11118.6
7374.4
2608.5
3301.3
2346.3
1930.7
2487.8
2513.9
3304.9
9011.4

cash-flows.row.operating-cash-flow

0839.1-62294508.7
-2669
13185.4
6110
1335.4
-11683.5
1363.4
-775.2
6510.5
6673.9
5814.6
9407.3
13074.1
3263.8
6801.1

cash-flows.row.capital-expenditure

0-5106.2-5567.7-6750.9
-14289.2
-8736.5
-10069.7
-4534
-2215.7
-637.8
-1373.6
-1031.9
-496.3
-392.7
-983.8
-2887.1
-2400.5
-14825.2

cash-flows.row.free-cash-flow

0-4267.1-11796.7-2242.2
-16958.2
4448.9
-3959.7
-3198.6
-13899.2
725.5
-2148.7
5478.5
6177.7
5422
8423.4
10187
863.4
-8024.2

Resultatopgørelse række

Yuyu Pharma, Inc.s omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for 000225.KS rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172015201420132012201120102009200820072006

income-statement-row.row.total-revenue

0137209.6138881.1115655.5
98119.8
90877.6
83096.4
62852.1
69743.4
62816.2
61994.1
61984.7
58798.7
52027.3
47900.3
45014.2
73840.1
73393.1

income-statement-row.row.cost-of-revenue

090704.585567.970320.1
52850.9
44267.3
42459.5
32866.4
38870.8
31717.2
29623.1
26630.2
25563.8
21237.5
21042.2
18076.9
26306.4
26153.2

income-statement-row.row.gross-profit

046505.153313.145335.4
45269
46610.3
40636.9
29985.7
30872.6
31099
32371
35354.5
33234.9
30789.9
26858.2
26937.3
47533.7
47240

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-219.225291.423750.8
20742.9
21602
322.2
-183.7
1061.2
-6648.9
645.9
64.9
40.3
1011.7
562.1
1928.3
-7.2
312.8

income-statement-row.row.operating-expenses

047254.153905.344135.2
38998
38535.6
35309.2
26417.5
29258.8
29728.1
30615.9
31635.2
31133.5
29496.3
26270.4
32671.2
37529.6
34169.6

income-statement-row.row.cost-and-expenses

0137958.5139473.2114455.3
91848.9
82802.9
77768.7
59283.9
68129.6
61445.3
60238.9
58265.4
56697.3
50733.7
47312.6
50748
63836
60322.7

income-statement-row.row.interest-income

0896.7561.7201
166
340.4
250.6
131.4
117.1
241.2
221.8
159.3
156.3
543.1
424.6
1020.2
1056.3
243

income-statement-row.row.interest-expense

02553.82580.72175.4
1758.6
1786.6
1121.3
381
296.9
303.6
255.6
246.2
431.6
561.2
1192.2
2103.2
2047.3
1747.5

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-4199.5-4502.1-3036.7
-2559.6
-1474.5
-679.2
1245.1
-3552.3
-9043.5
3
-133.1
-471.2
-1565.7
2050.2
-2493.5
5571.4
-910.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-219.225291.423750.8
20742.9
21602
322.2
-183.7
1061.2
-6648.9
645.9
64.9
40.3
1011.7
562.1
1928.3
-7.2
312.8

income-statement-row.row.total-operating-expenses

0-4199.5-4502.1-3036.7
-2559.6
-1474.5
-679.2
1245.1
-3552.3
-9043.5
3
-133.1
-471.2
-1565.7
2050.2
-2493.5
5571.4
-910.4

income-statement-row.row.interest-expense

02553.82580.72175.4
1758.6
1786.6
1121.3
381
296.9
303.6
255.6
246.2
431.6
561.2
1192.2
2103.2
2047.3
1747.5

income-statement-row.row.depreciation-and-amortization

05607.35027.44503
3048.1
2948.2
2127
1460.9
1542.2
1510.4
1632.5
1549
1694.8
2245.8
2690.3
3313.8
4588.9
4898.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-748.9691.72653.5
6270.9
8074.7
5327.4
3568.2
1613.8
1370.9
1755.2
3719.3
1819.3
1293.6
587.7
-5733.8
10004.1
13070.4

income-statement-row.row.income-before-tax

0-4948.5-3810.4-383.2
3711.3
6600.3
4648.2
4813.3
-281.5
-7672.6
2629.6
3586.2
1348.1
860
2638
-5454.6
15575.5
12160

income-statement-row.row.income-tax-expense

098.4615537.1
1298.7
1036.9
336.1
524.8
122.2
-309.2
697.8
600.2
-560.1
-257.2
364.6
232.7
2009.4
3601.6

income-statement-row.row.net-income

0-7180.9-4425.4-920.3
2412.6
4722.3
4020.3
4541.4
-252.7
-7467.4
1876.5
2978.7
1906.8
1117.3
2273.4
-5687.4
13566.1
8558.4

Ofte stillede spørgsmål

Hvad er Yuyu Pharma, Inc. (000225.KS) samlede aktiver?

Yuyu Pharma, Inc. (000225.KS) samlede aktiver er 198213526767.000.

Hvad er virksomhedens årlige omsætning?

Den årlige omsætning er N/A.

Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er 0.352.

Hvad er virksomhedens frie pengestrøm?

Det frie cash flow er -285.886.

Hvad er virksomhedens nettoprofitmargin?

Nettofortjenstmargenen er -0.050.

Hvad er firmaets samlede omsætning?

Den samlede omsætning er -0.001.

Hvad er Yuyu Pharma, Inc. (000225.KS) nettoresultat (nettoindkomst)?

Nettoresultatet (nettoindkomsten) er -7180899668.000.

Hvad er virksomhedens samlede gæld?

Den samlede gæld er 39407153086.000.

Hvad er tallet for driftsudgifter?

Driftsudgifterne er 47254050269.000.

Hvad er firmaets likviditet?

Virksomhedens likviditet er 0.000.